Florence Myrick

653 total citations
11 papers, 507 citations indexed

About

Florence Myrick is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Florence Myrick has authored 11 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Virology and 4 papers in Molecular Biology. Recurrent topics in Florence Myrick's work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (5 papers). Florence Myrick is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (5 papers). Florence Myrick collaborates with scholars based in United States, France and Canada. Florence Myrick's co-authors include Katyna Borroto–Esoda, Michael D. Miller, Evguenia S. Svarovskaia, Joy Y. Feng, Adrian S. Ray, Jennifer E. Vela, Kirsten White, Derrick Goodman, Maria Curtis and Jenny Heathcote and has published in prestigious journals such as Hepatology, Antimicrobial Agents and Chemotherapy and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Florence Myrick

11 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florence Myrick United States 9 362 242 222 159 97 11 507
Brenda I. Hernández-Santiago United States 9 307 0.8× 114 0.5× 167 0.8× 119 0.7× 143 1.5× 16 451
Lotke Tambuyzer Belgium 13 521 1.4× 399 1.6× 211 1.0× 182 1.1× 57 0.6× 23 631
Cyril Llamoso United States 13 246 0.7× 188 0.8× 354 1.6× 326 2.1× 33 0.3× 33 565
Murty N. Arimilli United States 8 242 0.7× 152 0.6× 147 0.7× 48 0.3× 142 1.5× 9 410
Maxwell D. Leslie United States 9 250 0.7× 218 0.9× 96 0.4× 33 0.2× 75 0.8× 11 313
Tania Ivens Belgium 9 624 1.7× 473 2.0× 214 1.0× 220 1.4× 95 1.0× 14 772
Els Fransen Sweden 4 328 0.9× 187 0.8× 193 0.9× 214 1.3× 44 0.5× 4 420
Margaret Gartland United States 9 201 0.6× 174 0.7× 156 0.7× 148 0.9× 82 0.8× 15 404
Christel Van den Eynde Belgium 8 640 1.8× 592 2.4× 126 0.6× 120 0.8× 79 0.8× 13 764
J. Kruining Netherlands 10 203 0.6× 69 0.3× 309 1.4× 216 1.4× 95 1.0× 18 417

Countries citing papers authored by Florence Myrick

Since Specialization
Citations

This map shows the geographic impact of Florence Myrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Myrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Myrick more than expected).

Fields of papers citing papers by Florence Myrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Myrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Myrick. The network helps show where Florence Myrick may publish in the future.

Co-authorship network of co-authors of Florence Myrick

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Myrick. A scholar is included among the top collaborators of Florence Myrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Myrick. Florence Myrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Snow‐Lampart, Andrea, Maria Curtis, Yuao Zhu, et al.. (2010). No Resistance to Tenofovir Disoproxil Fumarate Detected After up to 144 Weeks of Therapy in Patients Monoinfected With Chronic Hepatitis B Virus Δ. Hepatology. 53(3). 763–773. 138 indexed citations
2.
Feng, Joy Y., Florence Myrick, Derrick Goodman, et al.. (2009). The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study. Retrovirology. 6(1). 44–44. 54 indexed citations
3.
Svarovskaia, Evguenia S., Joy Y. Feng, Nicolas Margot, et al.. (2008). The A62V and S68G Mutations in HIV-1 Reverse Transcriptase Partially Restore the Replication Defect Associated With the K65R Mutation. JAIDS Journal of Acquired Immune Deficiency Syndromes. 48(4). 428–436. 48 indexed citations
4.
Cihlář, Tomáš, Adrian S. Ray, Constantine G. Boojamra, et al.. (2007). Design and Profiling of GS-9148, a Novel Nucleotide Analog Active against Nucleoside-Resistant Variants of Human Immunodeficiency Virus Type 1, and Its Orally Bioavailable Phosphonoamidate Prodrug, GS-9131. Antimicrobial Agents and Chemotherapy. 52(2). 655–665. 75 indexed citations
5.
Myrick, Florence, Joy Y. Feng, Evguenia S. Svarovskaia, Maria Miller, & Katyna Borroto–Esoda. (2007). The Triple Combination of Tenofovir, Emtricitabine and Efavirenz Shows Synergistic Anti-HIV-1 Activity In Vitro. Antiviral Research. 74(3). A61–A61. 4 indexed citations
6.
Feng, Joy Y., Florence Myrick, Nicolas Margot, et al.. (2006). Virologic and Enzymatic Studies Revealing the Mechanism of K65R- and Q151M-Associated HIV-1 Drug Resistance Towards Emtricitabine and Lamivudine. Nucleosides Nucleotides & Nucleic Acids. 25(1). 89–107. 20 indexed citations
7.
Borroto–Esoda, Katyna, Jennifer E. Vela, Florence Myrick, Adrian S. Ray, & Michael D. Miller. (2006). In Vitro Evaluation of the Anti-HIV Activity and Metabolic Interactions of Tenofovir and Emtricitabine. Antiviral Therapy. 11(3). 377–384. 57 indexed citations
8.
Feng, Jiao, Florence Myrick, Boulbaba Selmi, et al.. (2005). Effects of HIV Q151M-associated multi-drug resistance mutations on the activities of (−)-β-d-1′,3′-dioxolan guanine. Antiviral Research. 66(2-3). 153–158. 5 indexed citations
9.
Ray, Adrian S., Florence Myrick, Jennifer E. Vela, et al.. (2005). Lack of a Metabolic and Antiviral Drug Interaction between Tenofovir, Abacavir and Lamivudine. Antiviral Therapy. 10(3). 451–457. 29 indexed citations
10.
Borroto–Esoda, Katyna, Florence Myrick, Joy Y. Feng, Jerry Jeffrey, & Phillip A. Furman. (2004). In Vitro Combination of Amdoxovir and the Inosine Monophosphate Dehydrogenase Inhibitors Mycophenolic Acid and Ribavirin Demonstrates Potent Activity against Wild-Type and Drug-Resistant Variants of Human Immunodeficiency Virus Type 1. Antimicrobial Agents and Chemotherapy. 48(11). 4387–4394. 29 indexed citations
11.
Myrick, Florence, et al.. (2002). Dioxolane Guanosine, the Active Form of the Prodrug Diaminopurine Dioxolane, Is a Potent Inhibitor of Drug-Resistant HIV-1 Isolates From Patients for Whom Standard Nucleoside Therapy Fails. JAIDS Journal of Acquired Immune Deficiency Syndromes. 29(1). 11–20. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026